Post-infectious bronchiolitis obliterans in children: is general quality of life the right measure?^☆,☆☆

In recent years, the long-term survival of many chronic progressive pulmonary diseases has improved; with such progress, the attention has also shifted from strictly focusing on physiological measurements of lung function and other physical characteristics to incorporating quality of life (QOL) assessments, with the latter reflecting a degree of interdependency with the severity of the respiratory condition. For example, in patients with cystic fibrosis (CF), factors such as body mass index, a correlate of nutritional status, and FEV1, a reporter of overall expiratory flow limitation and bronchial involvement, have emerged as important factors contributing to QOL.¹ Similarly, the frequency of hospital admissions for pulmonary exacerbations, sleep quality, adherence, depression, and physical activity measures are also major contributors to QOL ratings in CF.^2-7 As a corollary, reduced QOL is reported by children with non-CF bronchiectatic diseases⁸ and disease-specific QOL tools have been developed for assessing asthmatic children,^9-11 further reinforcing the importance of a comprehensive evaluation that attests to integrative functioning in the context of chronic illness, while also potentially serving as an objective follow-up and longitudinal monitoring instrument.¹² In this context, Sarria et al. now report their QOL findings among 34 children suffering from post-infectious bronchiolitis obliterans (PIBO) compared to 34 controls.¹³ PIBO is a frequently irreversible obstructive lung disease characterized by sub-epithelial inflammation and fibrotic narrowing of the smaller airways following a lower respiratory tract infection during early childhood. Despite its typical history and clinical examination, the diagnosis is characteristically confirmed by bioptic histopathological assessments along with pertinent radiological findings consisting of heterogeneous vascular perfusion alterations along with air trapping with or without bronchiectasis.^14,15 Indeed, since lung function tests are either not feasible or require specialized settings in young children, implementation of such approaches for the diagnosis of PIBO is woefully inadequate at best.^16-20 As would be anticipated from patients suffering from chronic obstructive respiratory symptoms that are likely to affect their capacity for physical activity, as well as other functions during day and night,²¹ the overall QOL was reduced in PIBO patients in both the health-related and school-related domains of the well-validated instrument that was used.²² Thus, the findings attest to the significant impact that this relatively rare, yet important diagnostic entity imposes on living conditions. Some limitations to this study deserve comment, to instigate future research. First, it would have been of interest to explore potential associations between available spirometric measurements and QOL measures, Secondly, the inclusion of a physical activity test such as the six-minute walk test (6-MWT) would be highly desirable, as would be the evaluation with overnight polysomnography (PSG); the potential independent contributions of 6-MWT performance and PSG findings to QOL could provide further insights as to the major determinants of QOL. Finally, and as raised by the investigators, future longitudinal periodic and concurrent assessments of clinical, radiological, functional, and QOL measures may shed some light as to the potentially important value of assessing QOL as a readily available, yet easy to obtain score that provides insights into disease severity, response to therapy, and prognostic tracking.

In summary and unsurprisingly, similar to many chronic respiratory diseases, PIBO adversely affects QOL in children. This interesting article should be a reminder to all of us pediatricians that the term “breath of life” is meaningful and should not be taken for granted.

• ☆
  Please cite this article as: Gozal D. Post-infectious bronchiolitis obliterans in children: is general quality of life the right measure?. J Pediatr (Rio J). 2018;94:340-1.
• ☆☆
  See paper by Sarria et al. in pages 374-9.

References

• ¹
  Habib A-RR, Manji J, Wilcox PG, Javer AR, Buxton JA, Quon BS. A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis. Ann Am Thorac Soc. 2015;12:420-428.
• ²
  Hebestreit H, Kriemler S, Radtke T. Exercise for all cystic fibrosis patients: is the evidence strengthening?. Curr Opin Pulm Med. 2015;21:591-595.
• ³
  Solem CT, Vera-Llonch M, Liu S, Botteman M, Castiglione B. Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis. Health Qual Life Outcomes. 2016;14:63.
• ⁴
  Vandekerckhove K, Keyzer M, Cornette J, Coomans I, Pyl F, De Baets F, et al. Exercise performance and quality of life in children with cystic fibrosis and mildly impaired lung function: relation with antibiotic treatments and hospitalization. Eur J Pediatr. 2017;176:1689-1696.
• ⁵
  Vandeleur M, Walter LM, Armstrong DS, Robinson P, Nixon GM, Horne RS. Quality of life and mood in children with cystic fibrosis: associations with sleep quality. J Cyst Fibros. 2017;:.
• ⁶
  van Horck M, Winkens B, Wesseling G, de Winter-de Groot K, de Vreede I, Jöbsis Q, et al. Factors associated with changes in health-related quality of life in children with cystic fibrosis during 1-year follow-up. Eur J Pediatr. 2017;176:1047-1054.
• ⁷
  Knudsen KB, Pressler T, Mortensen LH, Jarden M, Skov M, Quittner AL, et al. Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis. Springerplus. 2016;5:1216.
• ⁸
  Nathan AM, de Bruyne JA, Eg KP, Thavagnanam S. Review: quality of life in children with non-cystic fibrosis bronchiectasis. Front Pediatr. 2017;5:84.
• ⁹
  Roncada C, Mattiello R, Pitrez PM, Sarria EE. Specific instruments to assess quality of life in children and adolescents with asthma. J Pediatr (Rio J). 2013;89:217-225.
• ¹⁰
  Everhart RS, Fiese BH. Asthma severity and child quality of life in pediatric asthma: a systematic review. Patient Educ Couns. 2009;75:162-168.
• ¹¹
  Chiou CF, Weaver MR, Bell MA, Lee TA, Krieger JW. Development of the multi-attribute Pediatric Asthma Health Outcome Measure (PAHOM). Int J Qual Health Care. 2005;17:23-30.
• ¹²
  Juniper EF. How important is quality of life in pediatric asthma?. Pediatr Pulmonol Suppl. 1997;15:17-21.
• ¹³
  Sarria EE, Mundstock E, Machado DG, Mocelin HT, Fischer GB, Furlan SP, et al. Health-related quality of life in patients with bronchiolitis obliterans. J Pediatr (Rio J). 2018;94:374-379.
• ¹⁴
  Zhang L, Irion K, da Silva Porto N, Abreu e Silva F. High-resolution computed tomography in pediatric patients with postinfectious bronchiolitis obliterans. J Thorac Imaging. 1999;14:85-89.
• ¹⁵
  Mattiello R, Sarria EE, Mallol J, Fischer GB, Mocelin H, Bello R, et al. Post-infectious bronchiolitis obliterans: can CT scan findings at early age anticipate lung function?. Pediatr Pulmonol. 2010;45:315-319.
• ¹⁶
  Colom AJ, Teper AM. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children. Pediatr Pulmonol. 2009;44:1065-1069.
• ¹⁷
  Mosquera RA, Hashmi SS, Pacheco SE, Reverdin A, Chevallier J, Colasurdo GN. Dysanaptic growth of lung and airway in children with post-infectious bronchiolitis obliterans. Clin Respir J. 2014;8:63-71.
• ¹⁸
  Cazzato S, Poletti V, Bernardi F, Loroni L, Bertelli L, Colonna S, et al. Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans. Pediatr Pulmonol. 2008;43:381-390.
• ¹⁹
  Aguerre V, Castanos C, Pena HG, Grenoville M, Murtagh P. Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function findings. Pediatr Pulmonol. 2010;45:1180-1185.
• ²⁰
  Lee E, Yoon J, Cho HJ, Hong SJ, Yu J. Respiratory reactance in children aged three to five years with postinfectious bronchiolitis obliterans is higher than in those with asthma. Acta Paediatr. 2017;106:81-86.
• ²¹
  Mattiello R, Sarria EE, Stein R, Fischer GB, Mocelin HT, Barreto SS, et al. Functional capacity assessment in children and adolescents with post-infectious bronchiolitis obliterans. J Pediatr (Rio J). 2008;84:337-343.
• ²²
  Klatchoian DA, Len CA, Terreri MT, Silva M, Itamoto C, Ciconelli RM, et al. Quality of life of children and adolescents from São Paulo: reliability and validity of the Brazilian version of the Pediatric Quality of Life Inventory TM version 4.0 Generic Core Scales. J Pediatr (Rio J). 2008;84:308-315.

Publication Dates

• Publication in this collection
  Jul-Aug 2018